Archives sofinnova-ventures

by in
Entry Author Date Location
Guavus Obtains $30,000,000 New Financing Round 01/10/13 San Francisco
Labrys Biologics Secures $31,000,000 Series A Funding Round 01/04/13 San Francisco
Flexion Therapeutics Obtains $20,000,000 Series B Funding 12/04/12 Boston
Exclusive: Skyline Ventures Cuts Partners, Postpones Fundraising 10/26/12 National
Mirna Therapeutics Secures $34,500,000 Series C Funding Round 10/24/12 Texas
Who Will Survive the Biotech VC Downturn? The Young and the Proven 10/22/12 National
San Diego’s Cebix Names CEO, Raises $30.9M to Advance Diabetes Drug 10/17/12 San Diego
Which VCs Are Poised to Cash In On the Biotech IPOs of 2012? 10/15/12 National
Alzheimer’s R&D Isn’t Doomed, it’s Learning From Failure 08/20/12 National
Kayak, VMware, 3M, & More Names from the Boston Deal Roundup 07/25/12 Boston
Histogenics Brings In $49M for Tissue Regeneration—and Recapitalization 07/24/12 Boston
Histogenics Receives $49,000,000 Series A Round 07/24/12 Boston
Histogenics Obtains $49,000,000 Series A Funding 07/24/12 Boston
San Diego Life Sciences Roundup: Halozyme, Sophiris, Arena, & More 07/12/12 San Diego
Sophiris Moves to Unlock Blockbuster Potential in New Prostate Drug 07/10/12 San Diego
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
CrestaTech Receives $13,000,000 New Funding Round 05/01/12 San Francisco
Biotech Can’t Sidestep Cost-Effectiveness Anymore 04/02/12 National
In Life Sciences Partnerships, You Must be Smart from the Beginning 01/20/12 San Diego
Cebix to Raise $20 Million for Pivotal Trial of Diabetes Supplement 01/10/12 San Diego
Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better 10/24/11 National
Khosla, Sunpreme, Grockit: Bay Area BizTech News by the Numbers 10/17/11 San Francisco
Sofinnova Ventures Defies the Grim Mood, Raises $440M For Biotech-Only VC Fund 10/17/11 San Francisco
SARCode Secures $44,000,000 Series B Round 07/18/11 San Francisco
Sorbent Therapeutics Seeks to Fight Heart Failure in Unusual Arena: The Gut 07/13/11 San Francisco
SpineVision Obtains $5,000,000 New Financing 07/06/11 San Francisco
Sorbent Therapeutics Absorbs $36M to Go After New Treatment For Kidney, Heart Failure 06/30/11 San Francisco
Sorbent Therapeutics Obtains $36,000,000 Series B Financing Round 06/30/11 San Francisco
BioAmber Secures $45,000,000 Series B Financing 05/04/11 Detroit
See You Tonight at “San Diego’s Fight Against Diabesity” 01/27/11 San Diego
Page 2 of 4 « previous page · next page »